Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Stellate Ganglion Block Treatment on Long COVID Symptoms: A Single-Blind, Single-Center Randomized Controlled Trial (STAR-CO)

NCT07374562 is registered in ClinicalTrials.gov with Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec as lead sponsor.

NCT NCT07374562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07374562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Stellate Ganglion Block Treatment on Long COVID Symptoms: A Single-Blind, Single-Center Randomized Controlled Trial (STAR-CO)
Lead sponsor
Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
Phase
Not applicable
Overall status
Recruiting
Start date
February 5, 2026
Completion date
February 28, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid